E-LIB Suche - Ergebnisse für: Bodó, Imre

1

LGL-leukémia: Dasatinib mellett molekuláris remisszióban lé..:

Timár, Botond ; Szalóki, Gábor ; Zajta, Erik..
Hematológia–Transzfuziológia. , 2024

Link: https://doi.org/10.1556/..

2

Case Report: Effective management of adalimumab-induced acq..:

Ceglédi, Andrea ; Bátai, Árpád ; Dolgos, János...
Pathology and Oncology Research. 30 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

3

Delayed spontaneous remission of acquired factor V inhibito..:

Ceglédi, Andrea ; Dolgos, János ; Fekete, Mónika...
Pathology and Oncology Research. 29 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

4

Matrilineal Composition of the Reconstructed Stock of the S..:

Gáspárdy, András ; Wagenhoffer, Zsombor ; Fürlinger, Dóra...
Agriculture. 13 (2023) 2 - p. 456 , 2023

Link: https://doi.org/10.3390/..

5

von Willebrand factor neutralizing and non-neutralizing all..:

Pagliari, Maria Teresa ; Budde, Ulrich ; Baronciani, Luciano...
Journal of Thrombosis and Haemostasis. 21 (2023) 4 - p. 787-799 , 2023

Link: https://doi.org/10.1016/..

6

Use of thrombopoietin receptor agonists in adults with immu..:

Pulanić, Dražen ; Bátorová, Angelika ; Bodó, Imre...
Annals of Hematology. 102 (2023) 4 - p. 715-727 , 2023

Link: https://doi.org/10.1007/..

7

MM-570 Real-World Results With Daratumumab-Bortezomib-Dexam..:

Szita, Virág Réka ; Gaál, Lilla ; Ruff, Eszter...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S509 , 2023

Link: https://doi.org/10.1016/..

8

Complement Inhibition in Paroxysmal Nocturnal Hemoglobinuri..:

Bodó, Imre ; Amine, Ismail ; Boban, Ana...
Advances in Therapy. 40 (2023) 6 - p. 2752-2772 , 2023

Link: https://doi.org/10.1007/..

9

Combined immunosuppression for acquired hemophilia A: CyDRi..:

Simon, Barbara ; Ceglédi, Andrea ; Dolgos, János...
Blood. 140 (2022) 18 - p. 1983-1992 , 2022

Link: https://doi.org/10.1182/..

10

Case Report: A Child With Hemophilia A Serves as Donor for ..:

Kertész, Gabriella ; Kállay, Krisztián ; Kassa, Csaba...
Pathology and Oncology Research. 28 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

11

Von Willebrand factor propeptide and pathophysiological mec..:

Pagliari, Maria Teresa ; Rosendaal, Frits R. ; Ahmadinejad, Minoo...
Journal of Thrombosis and Haemostasis. 20 (2022) 5 - p. 1106-1114 , 2022

Link: https://doi.org/10.1111/..

12

Genotypes of European and Iranian patients with type 3 von ..:

Baronciani, Luciano ; Peake, Ian ; Schneppenheim, Reinhard...
Blood Advances. 5 (2021) 15 - p. 2987-3001 , 2021

Link: https://doi.org/10.1182/..

13

Clinical Utilization and Cost of Thrombophilia Testing in P..:

Gaddh, Manila ; Cheng, En ; Elsebaie, Maha A.T..
TH Open. 4 (2020) 3 - p. e153-e162 , 2020

Link: https://doi.org/10.1055/..

14

Rituximab leads to early elimination of circulating CD20+ T..:

Bodó, Imre ; Jaye, David L. ; Kotanchiyev, Sarah...
Blood Advances. 4 (2020) 3 - p. 477-481 , 2020

Link: https://doi.org/10.1182/..

15

Comparison of von Willebrand factor platelet‐binding activi..:

Szederjesi, Attila ; Baronciani, Luciano ; Budde, Ulrich...
Journal of Thrombosis and Haemostasis. 18 (2020) 10 - p. 2513-2523 , 2020

Link: https://doi.org/10.1111/..